Resources for Health Professionals


Praziquantel, adults, 5-10 mg/kg orally in a single-dose therapy. Praziquantel is not approved for treatment of children less than 4 years old but this drug has been used successfully to treat cases of D. caninum infection in children as young as 6 months.

Niclosamide is effective but is unvailable in the United States. No purge or follow-up stool examination is indicated, but appearance of proglottids after therapy is indication for retreatment. The infection is self-limiting in the human host and typically spontaneously clears by 6 weeks.* Oral praziquantel is available for human use in the United States.

* Niclosamide is NOT available for human use in the United States.

This information is provided as an informational resource for licensed health care providers as guidance only. It is not intended as a substitute for professional judgment.



Page last reviewed: May 21, 2020